Clinical Trials Browser

Not yet recruiting × Interventional × Female Breast Cancer Patients × Clear all

NCT06254066 2024-02-12

Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer

Phase 2 Not yet recruiting

Female Breast Cancer Patients